ID 11908
Alternative Names: ID-11908Latest Information Update: 25 Jan 2021
At a glance
- Originator Ildong Pharmaceutical
- Class Antidementias
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Research Alzheimer's disease
Most Recent Events
- 25 Jan 2021 ID 11908 is available for licensing as of 25 Jan 2021. https://www.ildong.com/
- 25 Jan 2021 Early research in Alzheimer's disease in South Korea (Ildong Pharmaceutical pipeline, January 2021)